Drug Metabolism And Pharmacokinetics

2 researchers across 2 institutions

2 Researchers
2 Institutions
0 Grant PIs
1 High Impact

Research in drug metabolism and pharmacokinetics investigates how the body processes and eliminates drugs, and how these processes influence drug efficacy and toxicity. Studies examine the absorption, distribution, metabolism, and excretion (ADME) of therapeutic agents and other xenobiotics. This involves understanding the enzymes responsible for drug metabolism, such as cytochrome P450s, and identifying how genetic variations, environmental factors, and disease states can alter these metabolic pathways. Researchers employ a range of techniques, including in vitro assays, animal models, and analytical chemistry methods to quantify drug concentrations in biological samples and elucidate metabolic profiles.

This area of study holds relevance for Arkansas by informing the development of safer and more effective medications, potentially impacting public health outcomes. Understanding drug metabolism is crucial for optimizing drug therapy in diverse patient populations, including those in rural communities who may face unique health challenges or have different genetic backgrounds. Furthermore, research into the metabolism of environmental contaminants or naturally occurring compounds found in Arkansas's agricultural and natural resources can contribute to public safety and environmental health initiatives.

This work draws on and contributes to multiple disciplines, including pharmacology, toxicology, biochemistry, and analytical chemistry. Connections exist with research in disease modeling, computational drug discovery, and the study of specific compounds like cannabinoids. Engagement spans across key research institutions within the state, fostering a collaborative environment for advancing knowledge in this critical field.

AI-generated overview
Filter by institution:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Anna Radomińska‐Pandya UAMS 41 6,149 High Impact
Kiara Fairman NCTR 7 105

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
5,071 works in 2026
+2.3% CAGR 2018–2026
Leadership concentration
4.5% held by global top 5 institutions
Fragmented HHI 15
Arkansas position
#60 globally
University of Arkansas for Medical Sciences, National Center for Toxicological Research

Top US institutions in this area

  1. 1 National Institutes of Health 1,613
  2. 2 University of Washington 1,509
  3. 3 Vanderbilt University 1,359
  4. 4 Pfizer (United States) 1,338
  5. 5 University of California, San Francisco 1,289
Browse All 2 Researchers in Directory